Latest Boardroom Shifts News

Aroa Biosurgery reported a 14% rise in product sales to NZ$44.6 million for the half-year ended September 2025, driven by strong growth in its Myriad portfolio. The company also posted a normalised EBITDA profit and reaffirmed its FY26 revenue and profit guidance.

Fleetwood Limited has announced the immediate departure of CEO Bruce Nicholson, with Chair John Klepec stepping in as interim CEO while a search for a permanent replacement begins.

Web Travel Group Limited reports robust half-year results for FY26, with its B2B travel division WebBeds fueling a 20% revenue increase despite rising costs and finance pressures.

Race Oncology Limited has secured shareholder approval for a replacement Constitution at its 2025 Annual General Meeting, updating its corporate governance framework to align with current regulatory standards.

Bapcor Limited has reshaped its leadership with Lachlan Edwards appointed as Chair and Angus McKay stepping down from the Board to concentrate on turning around the business as CEO.

DroneShield Limited reaffirms strong business fundamentals with record revenues in 2025, while addressing recent media reports and initiating an independent governance review.

Belararox Ltd announces the immediate resignation of founding Managing Director Arvind Misra, with Chairman Neil Warburton stepping in as interim leader during the search for a new executive director.

Black Cat Syndicate announces a leadership transition with James Bruce appointed as Managing Director from April 2026, succeeding founder Gareth Solly who will remain as a Non-Executive Director.

The Star Entertainment Group has secured crucial regulatory approvals to convert a $300 million strategic investment by Bally’s Corporation and Investment Holdings into equity, setting the stage for board changes and a path toward financial recovery.

Reece Limited reported a modest revenue decline and earnings pressure in FY25 amid challenging markets but reinforced its long-term growth strategy with a significant share buyback and board renewal. Early FY26 trading shows sales growth driven by network expansion despite ongoing cost pressures.

Alterity Therapeutics announces significant board changes, including the retirement of founding chairman Geoffrey Kempler and appointment of CEO Dr David Stamler as Managing Director, aligning leadership with its Phase 3 clinical ambitions.

Autosports Group Limited reports record FY25 revenue and profit, while announcing a strategic acquisition of 10 Barry Bourke Motors dealerships in Victoria, signaling robust growth momentum into FY26.